Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08935_nanopub.RAEvcuMfUtsI0PSgAH6ey0j2-i6WOYXg8twULZD5ktyJk#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB08935 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08935 label "Obinutuzumab [drugbank:DB08935]" assertion.
- drugbank:DB08935 seeAlso gazyva-drug.htm assertion.
- drugbank:DB08935 seeAlso gazyva.html assertion.
- drugbank:DB08935 seeAlso DB08935 assertion.
- drugbank:DB08935 description "Obinutuzumab is a humanized monoclonal antibody used as a combination treatment with chlorambucil to treat patients with untreated chronic lymphocytic leukemia. It was approved by the FDA in November 2013 and is marketed under the brand name Gazyva. There is a black box warning of fatal Hepatitis B Virus (HBV) reactivation and fatal Progressive Multifocal Leukoencephalopathy (PML)." assertion.
- drugbank:DB08935 identifier "drugbank:DB08935" assertion.
- drugbank:DB08935 title "Obinutuzumab" assertion.
- drugbank:DB08935 drugbank_vocabulary:x-cas cas:949142-50-1 assertion.
- drugbank:DB08935 drugbank_vocabulary:drugbank-id "DB08935" assertion.
- drugbank:DB08935 bio2rdf_vocabulary:x-identifiers.org DB08935 assertion.
- drugbank:DB08935 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08935" assertion.
- drugbank:DB08935 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08935 bio2rdf_vocabulary:identifier "DB08935" assertion.
- drugbank:DB08935 drugbank_vocabulary:x-wikipedia wikipedia:Obinutuzumab assertion.
- drugbank:DB08935 drugbank_vocabulary:x-kegg kegg:D09321 assertion.
- drugbank:DB08935 drugbank_vocabulary:x-ndc ndc:50242-070-01 assertion.